brinzolamide/brimonidine tartrate
brinzolamide/brimonidine tartrate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including SIMBRINZA. Available dosage form: suspension/ drops.
Drug Details
- Generic Name
- brinzolamide/brimonidine tartrate
- Brand Names
- SIMBRINZA
- Application Number
- NDA204251
- Sponsor
- Alcon Laboratories, Inc.
- NDC Codes
- 1
- Dosage Forms
- SUSPENSION/ DROPS
- Routes
- OPHTHALMIC
- Active Ingredients
- BRINZOLAMIDE, BRIMONIDINE TARTRATE
Indications and Usage
1 INDICATIONS AND USAGE SIMBRINZA (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. SIMBRINZA is a combination of brinzolamide, a carbonic anhydrase inhibitor, and brimonidine tartrate, an alpha adrenergic agonist, indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. (1)